EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NF-κB in Thyroid Cancer: An Update

Elvira Crescenzi iD, Antonio Leonardi iD, Francesco Pacifico iD

International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11464

DOI: 10.3390/ijms252111464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Elvira Crescenzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Istituto per l'Endocrinologia e l'Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini, 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unione europea-Next Generation EU, Piano Nazionale di Ripresa e Resilienza (PNRR)—Missione 4 “Istruzione e Ricerca”—Componente C2—Investimento 1.1, Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale (PRIN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysregulated NF-κB basal activity is a common feature of human thyroid carcinomas, especially in poorly differentiated or undifferentiated forms that, even if rare, are often resistant to standard therapies, and, therefore, are uncurable. Despite the molecular mechanisms leading to NF-κB activation in thyroid cancer being only partially understood, during the last few years, it has become clear that NF-κB contributes in different ways to the oncogenic potential of thyroid neoplastic cells. Indeed, it enhances their proliferation and viability, promotes their migration to and colonization of distant organs, and fuels their microenvironment. In addition, NF-κB signaling plays an important role in cancer stem cells from more aggressive thyroid carcinomas. Interfering with the different upstream and/or downstream pathways that drive NF-κB activity in thyroid neoplastic cells is an attractive strategy for the development of novel therapeutic drugs capable of overcoming the therapy resistance of advanced thyroid carcinomas. This review focuses on the recent findings about the key functions of NF-κB in thyroid cancer and discusses the potential implications of targeting NF-κB in advanced thyroid carcinomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsNF-kappa BSignal TransductionHumansAnimalsNeoplastic Stem CellsTumor MicroenvironmentGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

NF-κBtarget genesthyroid cancer

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Istituto per l'Endocrinologia e l'Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini, 5, 80131 Naples, Italy.
  • Dipartimento di Medicina Molecolare e Biotecnologie Mediche, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.

ORCID-Profile: Elvira Crescenzi, Antonio Leonardi, Francesco Pacifico

Förderung

  • Unione europea-Next Generation EU
  • Piano Nazionale di Ripresa e Resilienza (PNRR)—Missione 4 “Istruzione e Ricerca”—Componente C2—Investimento 1.1
  • Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale (PRIN)

Zitieren

APA

Crescenzi, E., Leonardi, A., & Pacifico, F. (2024). NF-κB in Thyroid Cancer: An Update. International Journal of Molecular Sciences, 25(21), 11464. https://doi.org/10.3390/ijms252111464

Vancouver

Crescenzi E, Leonardi A, Pacifico F. NF-κB in Thyroid Cancer: An Update. International Journal of Molecular Sciences. 2024;25(21):11464. doi:10.3390/ijms252111464

BibTeX
@article{Crescenzi2024,
  author = {Crescenzi, Elvira and Leonardi, Antonio and Pacifico, Francesco},
  title = {NF-κB in Thyroid Cancer: An Update},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11464},
  doi = {10.3390/ijms252111464}
}
Kostenlos starten →